產品詳情
簡單介紹：
Anti-KIRREL1抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-KIRREL1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-KIRREL1
Cat. Number:
Anti-KIRREL1抗體KL-6435R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Neph1(Kirrel) belongs to a family of three closely related transmembrane proteins of the Ig superfamily with a structure similar to that of nephrin. Neph1 consists of a signal peptide, five Ig-like C2-type domains with the middleAnti-KIRREL1抗體 domain overlapping with a PKD-like domain, an RGD sequence, a transmembrane domain and a cytoplasmic tail. Neph1 is abundantly expressed in the kidney, specifically expressed in podocytes of kidney glomeruli, and plays a significant role in the normal development and function of the glomerular permeability. Neph1 interacts with nephrin in vitro and in vivo, and able to stimulate transcriptional activation in a model system, such as the activation the transcription factor AP-1 via the stimulation of a MAPK module. Neph1 is crucial for the integrity of the slit diaphragm, as Neph1 gene knockout mice results in effacement of glomerular podocytes, heavy proteinuria, and early postnatal death. .
Tissue specificity:
Abundantly expressed in kidney. Anti-KIRREL1抗體Specifically expressed in podocytes of kidney glomeruli.
Tissue specificity:
Abundantly expressed in kidney. Anti-KIRREL1抗體Specifically expressed in podocytes of kidney glomeruli.
Also known as:
Kin of IRRE like (Drosophila); Kin of IRRE like; Kin of IRRE like protein 1; Kin of IRRE-like protein 1; Kin of irregular chiasm like protein 1; Kin of irregular chiasm-like protein 1; KIRR1_HUMAN; Kirrel; MGC129542; MGC129543; NEPH 1; Anti-KIRREL1抗體NEPH1; Nephrin like protein 1; Nephrin related; Nephrin-like protein 1; KIRR1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human KIRREL1/.
●
Predicted Molecular Weight: 82kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-KIRREL1抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-KIRREL1抗體
Optimal working dilutions must be determined by the end user.
kl905Ra01 白介素7受體(IL7R)多克隆抗體 Polyclonal Antibody to Interleukin 7 Receptor (IL7R)
kl907Hu01 纖維膠凝蛋白2(FCN2)多克隆抗體 Polyclonal Antibody to Ficolin 2 (FCN2)
kl908Hu01 聚集蛋白聚糖(AGC)多克隆抗體 Polyclonal Antibody to Aggrecan (AGC)
kl908Mu01 聚集蛋白聚糖(AGC)多克隆抗體 Polyclonal Antibody to Aggrecan (AGC)
kl908Ra01 聚集蛋白聚糖(AGC)多克隆抗體 Polyclonal Antibody to Aggrecan (AGC)
kl909Hu01 p53上調凋亡調節因子(PUMA)多克隆抗體 Polyclonal Antibody to p53 Upregulated Modulator Of Apoptosis (PUMA)
kl909Ra01 p53上調凋亡調節因子(PUMA)多克隆抗體 Polyclonal Antibody to p53 Upregulated Modulator Of Apoptosis (PUMA)
kl910Hu01 激肽釋放酶7(KLK7)多克隆抗體 Polyclonal Antibody to Kallikrein 7 (KLK7)
kl910Mu01 激肽釋放酶7(KLK7)多克隆抗體 Polyclonal Antibody to Kallikrein 7 (KLK7)
kl912Hu01 防御素α5(DEFα5)多克隆抗體 Polyclonal Antibody to Defensin Alpha 5, kleth Cell Specific (DEFa5)
kl914Hu01 甲酰肽受體2(FPR2)多克隆抗體 Polyclonal Antibody to Formyl Peptide Receptor 2 (FPR2)
kl915Hu01 布魯東氏酪氨酸激酶(Btk)多克隆抗體 Polyclonal Antibody to Bruton'S Tyrosine Kinase (Btk)
kl918Mu01 蛋白激酶Cα(PKCα)多克隆抗體 Polyclonal Antibody to Protein Kinase C Alpha (PKCa)
kl918Ra01 蛋白激酶Cα(PKCα)多克隆抗體 Polyclonal Antibody to Protein Kinase C Alpha (PKCa)
kl919Hu01 血管生成素樣蛋白2(ANGPTL2)多克隆抗體 Polyclonal Antibody to Angiopoietin Like Protein 2 (ANGPTL2)
kl919Mu01 血管生成素樣蛋白2(ANGPTL2)多克隆抗體 Polyclonal Antibody to Angiopoietin Like Protein 2 (ANGPTL2)
kl921Hu01 血小板親和蛋白1(PKP1)多克隆抗體 Polyclonal Antibody to Plakophilin 1 (PKP1)
kl923Hu01 丙酮酸脫氫酶β(PDHβ)多克隆抗體 Polyclonal Antibody to Pyruvate Dehydrogenase Beta (PDHb)
kl923Mu01 丙酮酸脫氫酶β(PDHβ)多克隆抗體 Polyclonal Antibody to Pyruvate Dehydrogenase Beta (PDHb)
